We don't know whether the most recent response to this request contains information or not – if you are R Whyte please sign in and let everyone know.

Vanlafaxine - Bioavailability studies

R Whyte made this Official Information request to Pharmaceutical Management Agency

This request has an unknown status. We're waiting for R Whyte to read a recent response and update the status.

From: R Whyte

Dear Pharmaceutical Management Agency,

This is a official information request for any and all bioavailability and pharmacodynamic studies that were submitted to or are held by Pharmac for both the current and previous formulations of venlafaxine (Enlax XR, Effexor XR and Arrow Venlafaxine XR).

Yours faithfully,
R Whyte

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Dear R Whyte

 

This email is to acknowledge that your request for information under the
Official Information Act (1982) has been received and is currently being
worked on. We will have a reply to you as soon as possible and no later
than the due date of 17 April 2018.

 

 

Kind regards

Dean Zeng

PHARMAC

 

-----Original Message-----
From: R Whyte [mailto:[FOI #7459 email]]
Sent: Thursday, March 15, 2018 5:23 PM
To: Web Enquiry <[email address]>
Subject: [SPAM]? Official Information request - Vanlafaxine -
Bioavailability studies

 

Dear Pharmaceutical Management Agency,

 

This is a official information request for any and all bioavailability and
pharmacodynamic studies that were submitted to or are held by Pharmac for
both the current and previous formulations of venlafaxine (Enlax XR,
Effexor XR and Arrow Venlafaxine XR).

 

Yours faithfully,

R Whyte

 

-------------------------------------------------------------------

 

This is an Official Information request made via the FYI website.

 

Please use this email address for all replies to this request:

[1][FOI #7459 email]

 

Is [2][PHARMAC request email] the wrong address for Official Information
requests to Pharmaceutical Management Agency? If so, please contact us
using this form:

[3]https://fyi.org.nz/change_request/new?bo...

 

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:

[4]https://fyi.org.nz/help/officers

 

If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.

 

 

-------------------------------------------------------------------

 

**********************************************************************

This email and any files transmitted with it are confidential and

intended solely for the use of the individual or entity to whom they

are addressed. If you have received this email in error please notify

the system manager.

This footnote also confirms that this email message has been swept by

MIMEsweeper for the presence of computer viruses.

www.clearswift.com

**********************************************************************

References

Visible links
1. mailto:[FOI #7459 email]
2. mailto:[PHARMAC request email]
3. https://fyi.org.nz/change_request/new?bo...
4. https://fyi.org.nz/help/officers

hide quoted sections

Link to this

From: Web Enquiry
Pharmaceutical Management Agency


Attachment Request for Venlafaxine Bioavailability and Pharmacodynamics Data.pdf
154K Download View as HTML


Dear R Whyte

 

Please see attached the response to your OIA request.

 

 

Kind regards

Dean Zeng

PHARMAC

 

-----Original Message-----
From: R Whyte [mailto:[FOI #7459 email]]
Sent: Thursday, March 15, 2018 5:23 PM
To: Web Enquiry <[email address]>
Subject: [SPAM]? Official Information request - Vanlafaxine -
Bioavailability studies

 

Dear Pharmaceutical Management Agency,

 

This is a official information request for any and all bioavailability and
pharmacodynamic studies that were submitted to or are held by Pharmac for
both the current and previous formulations of venlafaxine (Enlax XR,
Effexor XR and Arrow Venlafaxine XR).

 

Yours faithfully,

R Whyte

 

-------------------------------------------------------------------

 

This is an Official Information request made via the FYI website.

 

Please use this email address for all replies to this request:

[1][FOI #7459 email]

 

Is [2][PHARMAC request email] the wrong address for Official Information
requests to Pharmaceutical Management Agency? If so, please contact us
using this form:

[3]https://fyi.org.nz/change_request/new?bo...

 

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:

[4]https://fyi.org.nz/help/officers

 

If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.

 

 

-------------------------------------------------------------------

 

**********************************************************************

This email and any files transmitted with it are confidential and

intended solely for the use of the individual or entity to whom they

are addressed. If you have received this email in error please notify

the system manager.

This footnote also confirms that this email message has been swept by

MIMEsweeper for the presence of computer viruses.

www.clearswift.com

**********************************************************************

References

Visible links
1. mailto:[FOI #7459 email]
2. mailto:[PHARMAC request email]
3. https://fyi.org.nz/change_request/new?bo...
4. https://fyi.org.nz/help/officers

hide quoted sections

Link to this

From: Web Enquiry
Pharmaceutical Management Agency


Attachment 2019 06 release of further information to Mr Whyte.pdf
70K Download View as HTML

Attachment 2019 06 10 Document for release with watermark.pdf
2.0M Download View as HTML


Dear Mt Whyte

Please find attached a response to you and the information requested.

 

Kind regards

Donna Jennings

PHARMAC

 

 

 

**********************************************************************

This email and any files transmitted with it are confidential and

intended solely for the use of the individual or entity to whom they

are addressed. If you have received this email in error please notify

the system manager.

This footnote also confirms that this email message has been swept by

MIMEsweeper for the presence of computer viruses.

www.clearswift.com

**********************************************************************

hide quoted sections

Link to this

We don't know whether the most recent response to this request contains information or not – if you are R Whyte please sign in and let everyone know.

Things to do with this request

Anyone:
Pharmaceutical Management Agency only: